Saira Ramasastry

Saira Ramasastry, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Mirum Pharmaceuticals, Inc., Sangamo Therapeutics, Inc and Vir Biotechnology, Inc. Over a trading history stretching from 17 March 2014 to 23 April 2026, the count stands at 58 filings.

Every open-market trade on record is a sale: 24 sales worth €3.2M. The amount is not disclosed for 1 filing. Other entries cover 13 share grants and 18 option exercises. 2026 to date brings no purchases and 4 sales.

On 23 April 2026 came the latest disclosure, a transaction in Day One Biopharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.